769 related articles for article (PubMed ID: 29493798)
21. Best practices in care for menopausal patients: 16 years after the Women's Health Initiative.
DeNeui T; Berg J; Howson A
J Am Assoc Nurse Pract; 2019 Jul; 31(7):420-427. PubMed ID: 30908403
[TBL] [Abstract][Full Text] [Related]
22. Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials.
Lorentzon M; Johansson H; Harvey NC; Liu E; Vandenput L; Crandall CJ; Cauley JA; LeBoff MS; McCloskey EV; Kanis JA
Osteoporos Int; 2022 Nov; 33(11):2297-2305. PubMed ID: 35833956
[TBL] [Abstract][Full Text] [Related]
23. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
Lukes A
J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
[TBL] [Abstract][Full Text] [Related]
24. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
25. Vasomotor symptoms and cardiovascular events in postmenopausal women.
Szmuilowicz ED; Manson JE; Rossouw JE; Howard BV; Margolis KL; Greep NC; Brzyski RG; Stefanick ML; O'Sullivan MJ; Wu C; Allison M; Grobbee DE; Johnson KC; Ockene JK; Rodriguez BL; Sarto GE; Vitolins MZ; Seely EW
Menopause; 2011 Jun; 18(6):603-10. PubMed ID: 21358352
[TBL] [Abstract][Full Text] [Related]
26. The Timing Hypothesis: Hormone Therapy for Treating Symptomatic Women During Menopause and Its Relationship to Cardiovascular Disease.
Mehta JM; Chester RC; Kling JM
J Womens Health (Larchmt); 2019 May; 28(5):705-711. PubMed ID: 30484736
[TBL] [Abstract][Full Text] [Related]
27. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
Chlebowski RT; Aragaki AK
Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
[TBL] [Abstract][Full Text] [Related]
28. The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
Bassuk SS; Manson JE
Metabolism; 2016 May; 65(5):794-803. PubMed ID: 27085786
[TBL] [Abstract][Full Text] [Related]
29. Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.
Du Y; Dören M; Melchert HU; Scheidt-Nave C; Knopf H
BMC Womens Health; 2007 Oct; 7():19. PubMed ID: 17945013
[TBL] [Abstract][Full Text] [Related]
30. What the future holds for women after menopause: where we have been, where we are, and where we want to go.
Lobo RA
Climacteric; 2014 Dec; 17 Suppl 2():12-7. PubMed ID: 25032478
[TBL] [Abstract][Full Text] [Related]
31. Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice.
Stute P; Marsden J; Salih N; Cagnacci A
Maturitas; 2023 Aug; 174():8-13. PubMed ID: 37209498
[TBL] [Abstract][Full Text] [Related]
32. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
33. Menopausal Hormone Therapy: a Comprehensive Review.
Lundberg G; Wu P; Wenger N
Curr Atheroscler Rep; 2020 Jun; 22(8):33. PubMed ID: 32556827
[TBL] [Abstract][Full Text] [Related]
34. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative.
Wild RA; Hovey KM; Andrews C; Robinson JG; Kaunitz AM; Manson JE; Crandall CJ; Paragallo R; Shufelt C; Merz CNB
Menopause; 2021 May; 28(6):610-618. PubMed ID: 33950030
[TBL] [Abstract][Full Text] [Related]
36. Emirati Women's Knowledge about the Menopause and Menopausal Hormone Therapy.
Smail L; Jassim GA; Sharaf KI
Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32640704
[TBL] [Abstract][Full Text] [Related]
37. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
Khalil RA
Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
[TBL] [Abstract][Full Text] [Related]
38. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants.
Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD
Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930
[TBL] [Abstract][Full Text] [Related]
39. Prescribing menopausal hormone therapy: an evidence-based approach.
Sood R; Faubion SS; Kuhle CL; Thielen JM; Shuster LT
Int J Womens Health; 2014; 6():47-57. PubMed ID: 24474847
[TBL] [Abstract][Full Text] [Related]
40. Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Anagnostis P; Paschou SA; Katsiki N; Krikidis D; Lambrinoudaki I; Goulis DG
Curr Vasc Pharmacol; 2019; 17(6):564-572. PubMed ID: 29984659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
